NR 566 FINAL EXAM QUESTIONS & ANSWERS 2026-2027 | CHAMBERLAIN UNI… EXAM
P R O F E S S I O N A L P R A C T I C E M AT E R I A L S
NR 566 Final Exam
Questions & Answers 2026-
2027 | Chamberlain
University
Verified Answers Exam Ready With Rationales
107 QUESTIONS
DOCUMENT OVERVIEW
This document contains 107 verified exam questions along with their correct answers, providing clear
explanations for each topic. It encompasses key concepts in nursing and pharmacology relevant to patient
care and treatment protocols. The resource is ideal for students preparing for exams, reviewing course
material, or seeking certification, ensuring a comprehensive understanding of essential nursing principles.
CONTENTS
• Hormonal Therapies • Reproductive Health
• Parkinson's Disease • Migraine Management
• Neurological Disorders • Mental Health Medications
• Antidepressants and Anxiolytics • Sleep Aids and Herbal Remedies
Page 1
, E XA M Q U EST I O N S
Q1 QUESTION 1 OF 107
Raloxifene (Evista) and bisphosphonates (alendronate, calcitonin)
CORRECT ANSWER
alternatives for hormone replacement therapy
Q2 QUESTION 2 OF 107
Selective Estrogen Receptor Modulators (SERMs)
CORRECT ANSWER
Tamoxifen, toremifene, raloxifene -- provide estrogen benefits while avoiding its drawbacks
Q3 QUESTION 3 OF 107
Dysfunctional uterine bleeding
CORRECT ANSWER
10-14 day course of progestin
Q4 QUESTION 4 OF 107
Amenorrhea treatment
CORRECT ANSWER
progestin helps induce menstrual flow
Q5 QUESTION 5 OF 107
Page 2
, Amenorrhea estrogen levels are low
CORRECT ANSWER
give progestin for 5-10 days
Q6 QUESTION 6 OF 107
Long term progestin therapy
CORRECT ANSWER
protection against endometrial cancer
Q7 QUESTION 7 OF 107
Estradiol
CORRECT ANSWER
most active estrogenic compound. oral estrogen option
Q8 QUESTION 8 OF 107
Advantages of estrogen transdermal patch
CORRECT ANSWER
lower total estrogen dose. less n/v. less fluctuation of estrogen blood levels. lower r/f DVT, PE and stroke
Q9 QUESTION 9 OF 107
Femring
CORRECT ANSWER
intravaginal ring controls hot flashes and night sweats. Treats vulval and vaginal atrophy
Page 3
P R O F E S S I O N A L P R A C T I C E M AT E R I A L S
NR 566 Final Exam
Questions & Answers 2026-
2027 | Chamberlain
University
Verified Answers Exam Ready With Rationales
107 QUESTIONS
DOCUMENT OVERVIEW
This document contains 107 verified exam questions along with their correct answers, providing clear
explanations for each topic. It encompasses key concepts in nursing and pharmacology relevant to patient
care and treatment protocols. The resource is ideal for students preparing for exams, reviewing course
material, or seeking certification, ensuring a comprehensive understanding of essential nursing principles.
CONTENTS
• Hormonal Therapies • Reproductive Health
• Parkinson's Disease • Migraine Management
• Neurological Disorders • Mental Health Medications
• Antidepressants and Anxiolytics • Sleep Aids and Herbal Remedies
Page 1
, E XA M Q U EST I O N S
Q1 QUESTION 1 OF 107
Raloxifene (Evista) and bisphosphonates (alendronate, calcitonin)
CORRECT ANSWER
alternatives for hormone replacement therapy
Q2 QUESTION 2 OF 107
Selective Estrogen Receptor Modulators (SERMs)
CORRECT ANSWER
Tamoxifen, toremifene, raloxifene -- provide estrogen benefits while avoiding its drawbacks
Q3 QUESTION 3 OF 107
Dysfunctional uterine bleeding
CORRECT ANSWER
10-14 day course of progestin
Q4 QUESTION 4 OF 107
Amenorrhea treatment
CORRECT ANSWER
progestin helps induce menstrual flow
Q5 QUESTION 5 OF 107
Page 2
, Amenorrhea estrogen levels are low
CORRECT ANSWER
give progestin for 5-10 days
Q6 QUESTION 6 OF 107
Long term progestin therapy
CORRECT ANSWER
protection against endometrial cancer
Q7 QUESTION 7 OF 107
Estradiol
CORRECT ANSWER
most active estrogenic compound. oral estrogen option
Q8 QUESTION 8 OF 107
Advantages of estrogen transdermal patch
CORRECT ANSWER
lower total estrogen dose. less n/v. less fluctuation of estrogen blood levels. lower r/f DVT, PE and stroke
Q9 QUESTION 9 OF 107
Femring
CORRECT ANSWER
intravaginal ring controls hot flashes and night sweats. Treats vulval and vaginal atrophy
Page 3
